Ignite Creation Date:
2024-05-06 @ 8:16 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06312345
Status:
RECRUITING
Last Update Posted:
2024-03-15
First Post:
2024-03-10
Brief Title:
Ciprofol Versus Propofol for Anesthesia Induction in Cardiac Surgery A Randomized Double-blind Controlled Clinical Trial
Sponsor:
Le Yu
Organization:
Shanghai East Hospital of Tongji University
Study Overview
Official Title:
Ciprofol Versus Propofol for Anesthesia Induction in Cardiac Surgery A Randomized Double-blind Controlled Clinical Trial
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Ciprofol a novel intravenous general anesthetic with a chemical structure akin to propofol boasts significantly enhanced potency It offers a rapid onset reduced incidence of injection pain and minor impact on the cardiovascular system However clinical research regarding ciprofols use for anesthesia induction in cardiac surgery remains limited
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None